Inflammatory bowel disease and pancreatic cancer: a Scandinavian register-based cohort study 1969-2017.

Åsa H Everhov Rune ErichsenMichael C SachsLars PedersenJonas HalfvarsonJohan AsklingAnders EkbomJonas F LudvigssonH T SørensenOla Olén

Published in: Alimentary pharmacology & therapeutics (2020)

Patients with IBD had an excess risk of pancreatic cancer, in particular patients with primary sclerosing cholangitis. However, the cumulative incidence difference after 20 years was small: 0.05%, that is, one extra pancreatic cancer per 2000 IBD patients.

Keyphrases

end stage renal disease
ulcerative colitis
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
risk factors
patient reported